Skip to main content

GTM & Risks

Target Users & Go-To-Market

Target Segments

Intensivists & Hospitalists

  • Work across multiple hospitals and EHRs
  • High cognitive load and frequent handoffs
  • Corvus offers a consistent personal cockpit and explicit context spine

Residents & Fellows

  • Need structure (I-PASS, problem lists, plans)
  • Need education (reasoning explanations, guidelines)
  • Corvus acts as guardrails + scaffold

Academic Hospitals & Training Programs Integrate Corvus into morning rounds, simulation training, and QI research.

Growth Tiers

  1. Free (Standalone): Individual clinicians. Smart Clipboard + Quad-View + basic Workbench.
  2. Team Tier (Paid): Groups as operational contexts. Shared handoff boards, patient assignment, analytics.
  3. Enterprise Tier: Custom guideline ingestion, On-prem/VPC, Governance, SSO.

Expansion Path

Our initial focus is acute care (ICU and hospital medicine), where cognitive load, data density, and workflow fragmentation are most severe.

Architectural primitives generalize:

  • Clinical Workspace becomes a longitudinal panel manager
  • Dual-Stream extends from ICU markers to chronic disease metrics
  • Check-to-accept and handoff patterns generalize to referrals and shared-care transitions

Risk, Regulatory & Execution

Regulatory Classification

Risk: Classification as SaMD/CADx if perceived as autonomous diagnosis/treatment.

Mitigation:

  • CADt Positioning: Framed as triage & documentation support.
  • Non-Autonomous Design: Check-to-accept ensures physician remains the decision-maker.
  • Conservative Prompting: Avoids imperative language.

Security & Compliance

Clinical Corvus is engineered to satisfy core HIPAA and LGPD safeguards.

  • Technical: CSP, HSTS, Rate Limiting, Audit Logging.
  • Administrative: BAA/DPA matrices, incident response playbooks.

Clinical Trust

Risk: Hallucinations and misaligned suggestions could erode confidence.

Mitigation:

  • Dual-stream pipeline (deterministic + narrative).
  • Citations & transparency.
  • Real-world evidence (RWE) from RAG traces.